Xphyto Therapeutics (CSE: XPHY) VP European Corporate Development and Managing Director at Bunker, Robert Barth joined Steve Darling on Skype from Germany with news the company has signed an agreement with the University of Munich and their Department of Bio-Chemistry.
Barth talks about what research they will do together and also when their facility “The Bunker” will be up and running.
Price: 2.26 CAD
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of XPhyto Therapeutics Corp. named herein, including the promotion by the Company of XPhyto Therapeutics Corp. in any Content on the Site, the...
FOR OUR FULL DISCLAIMER CLICK HERE
XPhyto Therapeutics (CSE: XPHY- OTC: XPHYF) CEO Hugh Rogers joined Steve Darling from Proactive to provide an update on their plans to go to market in Europe with their testing program for the COVID-19 Rogers talks about where that program is AT and also about their drug delivery platform...
Retail & consumer
